Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 218592 (Apr 25, 2025)

Issued April 25, 2025

Issued

April 25, 2025

Application

NDA 505b1 • 218592

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due April 25, 2026Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…